









Markets
/
Stocks
/
nasdaq-kytx
/

Kyverna Therapeutics Inc

KYTX

9.400USD

+0.410+4.56%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

411.66MMarket Cap

LossP/E TTM



Kyverna Therapeutics Inc

9.400

+0.410+4.56%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Kyverna Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q1

FY2022Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-57.59%-43.32M

-32.16%-31.95M

-75.96%-44.91M

-99.65%-37.06M

---27.49M

---24.18M

-122.77%-25.52M

-110.54%-18.56M

---11.46M

---8.82M

Net income from continuing operations

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.63M

-81.40%-37.49M

---34.49M

---28.80M

-139.55%-26.69M

-143.26%-20.67M

---11.14M

---8.50M

Operating gains losses

-25.63%415.00K

-2.83%515.00K

138.38%1.15M

21.86%563.00K

--558.00K

--530.00K

22.34%482.00K

23.53%462.00K

--394.00K

--374.00K

Other non-cash items

62.40%-835.00K

29.23%-1.13M

-671.54%-1.41M

-927.15%-1.55M

---2.22M

---1.59M

-19.61%246.00K

-153.93%-151.00K

--306.00K

--280.00K

Change in working capital

-268.53%-8.85M

86.64%8.23M

-18.82%-2.18M

-96.63%34.00K

--5.25M

--4.41M

-23.94%-1.84M

176.91%1.01M

---1.48M

---1.31M

-Change in prepaid expenses

5.33%-1.14M

-24.32%2.35M

85.23%-380.00K

15.23%-835.00K

---1.20M

--3.11M

-1498.14%-2.57M

-207.81%-985.00K

---161.00K

---320.00K

-Change in other current assets

-44.49%-958.00K

125.64%10.00K

-75.77%-515.00K

47.02%-960.00K

---663.00K

---39.00K

32.64%-293.00K

-214.58%-1.81M

---435.00K

---576.00K

-Change in other current liabilities

----

-188.89%-296.00K

--296.00K

----

141.83%333.00K

----

---796.00K

Cash from non-recurring investing activities

Cash from operating activities

-57.59%-43.32M

-32.16%-31.95M

-75.96%-44.91M

-99.65%-37.06M

---27.49M

---24.18M

-122.77%-25.52M

-110.54%-18.56M

---11.46M

---8.82M

Investing cash flow

Net cash from continuing investing activities

215.69%322.00K

-80.16%204.00K

-100.00%0.00

59.28%532.00K

--102.00K

--1.03M

1839.29%543.00K

2683.33%334.00K

--28.00K

--12.00K

Capital expenditures

284.31%392.00K

-80.16%204.00K

-100.00%0.00

59.28%532.00K

--102.00K

--1.03M

1839.29%543.00K

2683.33%334.00K

--28.00K

--12.00K

Net cash flow from disposal of fixed assets

-166.67%-68.00K

-99.61%4.00K

-100.00%0.00

59.28%532.00K

--102.00K

--1.03M

1839.29%543.00K

2683.33%334.00K

--28.00K

--12.00K

Net cash flow from intangible asset transactions

--390.00K

--200.00K

----

Net cash flow from investment products

2840.75%22.88M

143.91%29.37M

104.56%5.58M

-7.06%29.75M

--778.00K

---66.89M

-994.07%-122.34M

111.19%32.02M

--13.68M

--15.16M

Cash from non-current investing activities

Net cash flow from investing activities

3236.83%22.56M

142.94%29.17M

104.54%5.58M

-7.76%29.22M

--676.00K

---67.92M

-999.88%-122.88M

109.16%31.68M

--13.65M

--15.15M

Financing cash flow

Cash flow from continuous financing activities

1078.95%1.49M

-14.06%-649.00K

-100.12%-414.00K

85.01%-215.00K

---152.00K

---569.00K

234856.25%338.05M

-1305.88%-1.43M

---144.00K

---102.00K

Net cash flow from debt Issuance/repayment

50.41%-120.00K

-11.02%-262.00K

-47.62%-341.00K

-12.79%-247.00K

---242.00K

---236.00K

-37.50%-231.00K

-51.03%-219.00K

---168.00K

---145.00K

Net cash flow from common stock issuance/repurchase

--0.00

-100.00%0.00

--0.00

--341.17M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

Proceeds from stock option exercised by employees

1734.44%1.65M

-100.00%0.00

-95.31%3.00K

-88.36%32.00K

--90.00K

--73.00K

166.67%64.00K

539.53%275.00K

--24.00K

--43.00K

Net cash flow from other financing activities

---43.00K

4.68%-387.00K

97.43%-76.00K

100.00%0.00

--0.00

---406.00K

---2.96M

---1.49M

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

1078.95%1.49M

-14.06%-649.00K

-100.12%-414.00K

85.01%-215.00K

---152.00K

---569.00K

234856.25%338.05M

-1305.88%-1.43M

---144.00K

---102.00K

Net cash flow

Beginning cash balance

-59.16%53.99M

-74.46%57.42M

175.97%97.17M

347.24%105.23M

--132.19M

--224.86M

-8.04%35.21M

--23.53M

--38.29M

--0.00

Current period cash flow changes

28.51%-19.28M

96.30%-3.43M

-120.96%-39.75M

-168.93%-8.05M

---26.96M

---92.67M

9137.46%189.65M

87.60%11.68M

--2.05M

--6.23M

Ending cash balance

-67.01%34.72M

-59.16%53.99M

-74.46%57.42M

175.97%97.17M

--105.23M

--132.19M

457.38%224.86M

465.38%35.21M

--40.34M

--6.23M

Free cash flow

-58.43%-43.71M

-27.58%-32.15M

-72.30%-44.91M

-98.94%-37.59M

---27.59M

---25.20M

-126.95%-26.07M

-114.03%-18.90M

---11.49M

---8.83M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

